How much funding has Bitterroot Bio raised?

Bitterroot Bio has raised $145.0M in total funding, most recently a Series A round.

Who are Bitterroot Bio's investors?

Bitterroot Bio's investors include ARCH Venture Partners, Deerfield Management, GV, Koch Disruptive Technologies, Alexandria Venture Investments.

When was Bitterroot Bio founded?

Bitterroot Bio was founded in 2021.

Where is Bitterroot Bio headquartered?

Bitterroot Bio is headquartered in Palo Alto, California, United States.

What industry is Bitterroot Bio in?

Bitterroot Bio operates in Biotech.

How many employees does Bitterroot Bio have?

Bitterroot Bio has 11-50 employees.

Bitterroot Bio

Pioneering cardio-immunology to transform cardiovascular medicine

Palo Alto, United States · Founded 2021 · $145.0M raised

Biotech

Headquarters: Palo Alto, California
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: bitterrootbio.com
Total Funding: $145.0M
Last Round: $145.0M Series AJun 2023
Rounds: 1

About

Bitterroot Bio is a biotech company committed to pioneering cardio-immunology. Co-founded 2021 by Dr. Irv Weissman and Dr. Nick Leeper at Stanford. $145M Series A led by ARCH and Deerfield.

Summary

Bitterroot Bio is a Biotech company based in Palo Alto, United States, founded in 2021. It has raised $145.0M in total across 1 round, most recently a $145.0M Series A round in Jun 2023. Investors include ARCH Venture Partners, Deerfield Management and GV.

LinkedIn X (Twitter)